Abstract Details

Title Real‐World Utilization and Safety of OnabotulinumtoxinA for Chronic Migraine Headache Prophylaxis: Interim Analysis from an Observational Study in the European Union

Topic Headache

Presentation(s) (-)

Poster/Presentation
Number 209

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Manjit S. Matharu, MD PRESENTER	No disclosure on file
	No disclosure on file
A Ingela M Nilsson Remahl, MD (Karolinska University Hospital Huddinge)	No disclosure on file
Andreas Straube	Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Arlene Lum	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��